{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System",
        "BD Phoenix\u2122M Automated Microbiology System for use with the antimicrobial agent Piperacillin (2-128 \u03bcg/mL) - Gram-Negative ID/AST or AST only Phoenix panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K073433",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020321",
        "K041572"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "January 14, 2008",
    "Summary Letter Received Date": "December 6, 2007",
    "Submission Date": "December 4, 2007",
    "Regulation Number(s)": [
        "21CFR866.1645"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test System Short Incubation"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Piperacillin"
    ],
    "Specimen Type(s)": [
        "Isolates from pure culture of Gram-negative and Gram-positive bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix\u2122M Automated Microbiology System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Automated susceptibility testing",
        "Redox indicator detection"
    ],
    "Methodologies": [
        "Minimal inhibitory concentration determination",
        "Automated microbial identification",
        "Automated antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Reagent",
        "Instrument",
        "Software",
        "Broth",
        "Indicator solution"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix\u2122M Automated Microbiology System using Piperacillin for automated susceptibility testing of Gram-negative organisms",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration of most Gram-negative aerobic and facultative anaerobic bacteria isolates, and Gram-positive bacteria isolates from pure culture using Piperacillin (2-128 \u03bcg/mL), including removal of limitations for Proteus mirabilis, Providencia species, and Stenotrophomonas maltophilia",
    "fda_folder": "Microbiology"
}